⌘K

Home/Filings/4/0001048477-24-000061

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-24-000061

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 3:07 PM ET

Size

4.6 KB

Accession

0001048477-24-000061

Insider Transaction Report

Form 4

Period: 2024-04-10

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Sale
Common Stock
2024-04-10$90.00/sh−2,286$205,740→ 16,156 total

Footnotes (1)

[F1]Trade made pursuant to a 10b5-1 plan executed on November 29, 2023.

Documents

1 file

4
wk-form4_1712948853.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: Apr 11, 8:00 PM ET
Accepted: Apr 12, 3:07 PM ET
Size: 4.6 KB

View on SEC.gov